Vesugen
Khavinson tripeptide (Lys-Glu-Asp) marketed as a vascular bioregulator.
Scientific Overview
Vesugen is a Lys-Glu-Asp tripeptide from the Khavinson short-peptide series, positioned as a 'vasoprotective bioregulator'. Russian publications report effects on endothelial function and lipid markers in aged animals. Independent peer-reviewed replication is limited; mechanism claims of selective gene expression remain controversial.
Key Research Benefits
- ✓Claimed endothelial support
- ✓Studied in atherosclerosis (Russia)
Potential Side Effects
Research Protocols
Common DosagesResearch
“10-20 day cycles”
Dose Calculator
🧮 Peptide Reconstitution Calculator
Total amount of peptide in the vial.
Volume of water used to mix.
Draw to this mark
or 0.04 mL on a U-100 syringe
Explore Vesugen
Where to source
Vendors with public COAs that stock this category. Affiliate links are disclosed.
- Limitless Life NootropicsFL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.COA: JanoshikAffiliate disclosed
- SwissChems60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.COA: JanoshikAffiliate disclosed
- Amino ClubEU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.COA: Third-partyAffiliate disclosed
Vesugen by goal
Read Vesugen's profile filtered through specific research goals.
Molecular Profile
Quick Reference
- Status
- Research Compound
- Category
- Longevity
- Common Dosage
- 100-200 mcg
- Daily SC
Strictly for research purposes. Not for human consumption.
Related tools
Medical Disclaimer
Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.